Content Licensing Policy

Quest Press Limited / Macau Sino-Foreign Medical Publishing Limited (MSFMP)

To support our mission of maximizing the dissemination and reuse of scholarly work, Quest Press / MSFMP employs a standardized copyright and licensing framework for all content published across our portfolio of journals. This policy is designed to be transparent, aligned with international open science best practices, and supportive of author rights.

1. Standard Open Access License

All research articles, reviews, and other scholarly content published in our journals are made available under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0).

• Core Principle: This is a true open access model. Upon publication, the final Version of Record (VOR) is permanently and freely accessible to all readers worldwide without subscription or paywall barriers.

• User Rights: Under the CC BY 4.0 license, any user is permitted to:

  • Share — copy and redistribute the material in any medium or format.

  • Adapt — remix, transform, and build upon the material for any purpose, including commercial.

• Primary Condition: The only requirement is that proper attribution is given to the original work, including provision of a link to the license and an indication if changes were made. This attribution must credit the authors, the source journal, and the publisher.

2. Copyright Transfer & Author Rights

Under our standard publishing agreement, authors grant an exclusive license to publish the work to Quest Press Limited / MSFMP. Crucially, this agreement is structured to protect and extend author rights within the open access ecosystem.

• Authors Retain Significant Rights:

  • The moral right to be identified as the author of the work.

  • The right to share and reuse their article in various contexts, as detailed below.

• Third-Party Sharing: Authors are expressly permitted to share the published work (the VOR) with colleagues, on academic networking sites (e.g., ResearchGate, Academia.edu), and in teaching or conference materials, provided the CC BY license terms are followed.

3. Archiving Policy (Self-Archiving / Green Open Access)

We strongly support the deposition of scholarly work in repositories to ensure long-term preservation and accessibility. Authors have the right to self-archive their work without an embargo period.

• Permitted Versions: Authors may deposit the following versions of their manuscript:

  • Submitted Version (Preprint): The original version submitted to the journal before peer review.

  • Accepted Manuscript (AM): The final author-created version that incorporates all peer-review revisions but before the publisher's copyediting, typesetting, and branding.

  • Published Version (Version of Record - VOR): The final, formatted, and citeable PDF/HTML version as it appears on the journal's website.

• Repository Location: Authors may deposit these versions in:

  • Personal or professional websites/blogs

  • Institutional repositories of their affiliated university or research institute.

  • Subject-specific repositories (e.g., arXiv, SSRN, PubMed Central, if applicable).

• Requirement: When depositing the Accepted Manuscript or Published Version, a full citation and a link to the final article on the journal's official website must be included.

4. Rights for Reuse

The CC BY 4.0 license governs most reuse scenarios. For specific common academic uses, our policy is as follows:

• Teaching & Course Packs: Instructors may include the published work in printed or electronic course packs for classroom use without seeking further permission, under the terms of CC BY.

• Translation & Adaptations: Translating the article or creating adaptations (e.g., figures, tables for a review) is permitted, provided the derivative work is also shared under a CC BY license and proper attribution is given.

• Republication: Republication of the full article in another venue (e.g., a thesis, dissertation, or edited book) generally requires prior permission from the publisher. Please contact the editorial office for such requests.

5. Contact & Queries

This policy is intended to clarify the rights and responsibilities of all parties. For any questions regarding copyright, licensing, or the permissions process, please do not hesitate to contact our rights team.

Email: QuestPress@hotmail.com

Quest Press Limited
Macau Sino-Foreign Medical Publishing Limited (MSFMP)
November 14, 2025

内容许可政策

Quest Press Limited / Macau Sino-Foreign Medical Publishing Limited (MSFMP)

为支持我们最大限度传播和再利用学术成果的使命，Quest Press / MSFMP 为旗下所有期刊发表的内容采用标准化的版权与许可框架。本政策力求透明，符合国际开放科学最佳实践，并保障作者权利。

1. 标准开放获取许可

在本机构期刊发表的所有研究论文、综述及其他学术内容，均依据 《知识共享署名 4.0 国际许可协议》（CC BY 4.0） 的条款提供。

• 核心原则：此为真正的开放获取模式。文章一经发表，其最终出版版本（Version of Record, VOR）即永久免费向全球读者开放，无订阅或付费墙限制。

• 使用者权利：根据 CC BY 4.0 许可，任何用户被允许：

  • 共享 — 在任何媒介或格式中复制和再分发材料。

  • 演绎 — 出于任何目的（包括商业目的）对材料进行混编、转换或以该材料为基础进行创作。

• 主要条件：唯一的要求是进行恰当的署名。必须注明原作者信息，提供许可协议链接，并指明是否对原作品作了修改。署名必须包括作者、来源期刊及出版方信息。

2. 版权转让与作者权利

根据我们的标准出版协议，作者将作品的出版权以独占许可形式授予 Quest Press Limited / MSFMP。至关重要的是，该协议旨在保护并扩展作者在开放获取生态中的权利。

• 作者保留的重要权利：

  • 被确认为作品作者的人身权（署名权）。

  • 在符合许可条款的前提下，共享和再利用其文章的权利（具体见下）。

• 第三方分享：作者明确被允许在与同事分享、在学术社交网站（如 ResearchGate, Academia.edu）发布、以及用于教学或会议材料时分享已发表作品（VOR），前提是遵循 CC BY 许可条款。

3. 存储政策（自存档 / 绿色开放获取）

我们大力支持将学术成果存入知识库，以确保其长期保存和可获取性。作者有权无延迟（无禁运期）地自存档其作品。

• 允许存档的版本：作者可以存放其稿件的以下版本：

  • 投稿版本（预印本）：同行评审前提交给期刊的原始稿件。

  • 录用稿（Accepted Manuscript, AM）：经同行评审修订后的最终作者版本，但未经过出版方的排版、编辑和品牌化处理。

  • 出版版本（Version of Record - VOR）：在期刊官网上发布的最终、格式化、可供引用的 PDF/HTML 版本。

• 存储位置：作者可将这些版本存放于：

  • 个人或专业网站/博客

  • 所属大学或研究机构的机构知识库

  • 学科知识库（如 arXiv, SSRN, PubMed Central 等，若适用）。

• 要求：存放录用稿或出版版本时，必须包含完整的引用信息及指向期刊官网最终文章的链接。

4. 再利用权利

大多数再利用场景受 CC BY 4.0 许可管辖。针对特定的常见学术用途，我们的政策如下：

• 教学与课程资料：教师可根据 CC BY 条款，在印刷或电子版课程资料中使用已发表作品，无需另行申请许可。

• 翻译与改编：翻译文章或创建改编作品（例如，为综述使用其中的图表）是允许的，前提是衍生作品也以 CC BY 许可共享，并进行恰当署名。

• 再版：在另一出版物（如学位论文、专著或编辑的书籍）中全文再版文章，通常需要事先获得出版方许可。此类请求请联系编辑部。

5. 联系与咨询

本政策旨在阐明各方的权利与责任。如有任何关于版权、许可或授权流程的疑问，请随时联系我们。

电子邮箱: QuestPress@hotmail.com

Quest Press Limited
Macau Sino-Foreign Medical Publishing Limited (MSFMP)
2025年11月14日